Strategies of cardiovascular and ventilatory management in preterm infants with prolonged rupture of fetal membranes and oligohydramnios.
Kilbride
Howard W
HW
Thibeault
Donald W
DW
D000280:Administration, Inhalation; D002319:Cardiovascular System / Q000187:drug effects; D003131:Combined Modality Therapy; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D008297:Male; D009569:Nitric Oxide / Q000008:administration & dosage*; D016104:Oligohydramnios / Q000175:diagnosis / Q000628:therapy*; D011247:Pregnancy; D011663:Pulmonary Surfactants / Q000008:administration & dosage*; D012121:Respiration, Artificial / Q000379:methods; D012127:Respiratory Distress Syndrome, Newborn / Q000175:diagnosis / Q000628:therapy*; D018570:Risk Assessment; D016019:Survival Analysis; D016896:Treatment Outcome
D011663:Pulmonary Surfactants; D009569:Nitric Oxide